CFC Planning Company’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$2.95M Buy
2,547
+888
+54% +$1.05M 1.58% 23
2026
Q2
$1.99M Buy
1,659
+1
+0.1% +$1.02K 1.16% 32
2026
Q1
$1.53M Buy
1,658
+402
+32% +$408K 1.09% 31
2025
Q4
$1.35M Buy
1,256
+27
+2% +$25.8K 1.03% 31
2025
Q3
$938K Buy
1,229
+20
+2% +$14.9K 0.77% 31
2025
Q2
$943K Buy
1,209
+1
+0.1% +$777 0.89% 33
2025
Q1
$998K Buy
1,208
+59
+5% +$49.1K 1.07% 33
2024
Q4
$888K Buy
+1,149
New +$951K 0.95% 33

Other funds holding LLY

CFC Planning Company's LLY Position: Q3 2026 in Review

CFC Planning Company increased its Eli Lilly (LLY) stake by 54% in Q3 2026, buying an estimated $1.05M and bringing the position to 2,547 shares worth $2.95M. The position accounts for 1.58% of the portfolio, ranked #23.

CFC Planning Company first reported a position in LLY in Q4 2024 and has held it in 8 quarters since. 2,091 funds tracked by Wall St. Rank hold LLY as of Q3 2026.

  • CFC Planning Company held 2,547 shares of Eli Lilly worth $2.95M as of Q3 2026.
  • CFC Planning Company bought 888 Eli Lilly shares in Q3 2026, an estimated $1.05M.
  • Eli Lilly made up 1.58% of CFC Planning Company's portfolio in Q3 2026, its #23 holding.
  • CFC Planning Company first reported a position in Eli Lilly in Q4 2024 and has held it in 8 quarters since.
  • 2,091 funds tracked by Wall St. Rank held Eli Lilly as of Q3 2026.

Based on CFC Planning Company's 13F filing for Q3 2026, filed 28 Oct 2026.